Biohaven: Pay

Biohaven paid its 4 named executives $26.7M in total in FY2025 (Dec). CEO Vlad Coric, M.D. was paid $13.5M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Vlad Coric, M.D.Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Bruce CarChief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Matthew ButenChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Kimberly GentileSenior Vice President, Clinical Operations
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $9.2M. CEO pay of Biohaven for that year is not on file.

  1. 1Cogent Biosciences
  2. 2BridgeBio Pharma
  3. 3ImmunityBio
  4. 4Immunovant
  5. 5Xenon Pharmaceuticals
  6. 6Vir Biotechnology
  7. 7Vera Therapeutics
  8. 8Arvinas
  9. 9Denali Therapeutics
  10. 10BiohavenNot disclosed
  11. 11Anaptys BioNot disclosed
  12. 12Apellis PharmaceuticalsNot disclosed
  13. 13Arrowhead PharmaceuticalsNot disclosed
  14. 14Axsome TherapeuticsNot disclosed
  15. 15Crinetics PharmaceuticalsNot disclosed
  16. 16Intra-Cellular TherapiesNot disclosed
  17. 17Iovance BiotherapeuticsNot disclosed
  18. 18Longboard PharmaceuticalsNot disclosed
  19. 19Neumora TherapeuticsNot disclosed
  20. 20Rhythm PharmaceuticalsNot disclosed
  21. 21Sage TherapeuticsNot disclosed
  22. 22XencorNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.